Presentation THT 2026 Variation in Primary Graft Dysfunction Prevalence and Management Across Heart Transplant Centers Presenter: Malachy Belkhelladi March 03, 2026 REGISTER for free or LOG IN to view this content THT 2026 Up Next Presentation THT 2026 LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy Presenter: Dmitry Yaranov March 03, 2026 More slides + Presentation THT 2026 Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database. Presenter: Arvind Bhimaraj March 03, 2026 Presentation THT 2026 Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients Presenter: Brad Williams March 03, 2026 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation THT 2026 LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy Presenter: Dmitry Yaranov March 03, 2026
Presentation THT 2026 Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database. Presenter: Arvind Bhimaraj March 03, 2026
Presentation THT 2026 Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients Presenter: Brad Williams March 03, 2026